Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
Clinical trial NCT03475628 · UNKNOWN
Trial details
- NCT number
- NCT03475628
- Sponsor
- Hellenic Society of Hematology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2019-06-20
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.